Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Autophagy and biotransformation affect sorafenib resistance in hepatocellular carcinoma

Published:2023 Issue: Volume:21 Page:3564-3574
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Zheng Ruiqi^ORCID,Weng Shuang^ORCID,Xu Jianping,Li Zhuo,Wang Yaru,Aizimuaji Zulihumaer,Ma Sheng,Zheng Linlin,Li Haiyang^ORCID,Ying Wantao^ORCID,Rong Weiqi,Xiao Ting^ORCID

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. New insights on sorafenib resistance in liver cancer with correlation of individualized therapy;Cheng;Biochim Biophys Acta Rev Cancer,2020

3. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects;Tang;Signal Transduct Target Ther,2020

4. Sorafenib

5. New frontiers against sorafenib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers;He;Pharm Res,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in hepatocellular carcinoma drug resistance models;Frontiers in Medicine;2024-07-31

2. The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma;Critical Reviews in Oncology/Hematology;2024-05

3. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer;Journal of Integrative Medicine;2024-05

4. Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk;Cancer Letters;2024-04

5. LINC00540 promotes sorafenib resistance and functions as a ceRNA for miR-4677-3p to regulate AKR1C2 in hepatocellular carcinoma;Heliyon;2024-03